Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Shruti Saha
Institution:
Sun Pharma (India)
Observed institutions:
University of Mumbai,
King Edward Memorial Hospital and Seth G.S. Medical College,
Surya Hospitals,
Sun Pharma (India)
ORCID:
0000-0002-6593-9428
Observed ORCID:
0000-0002-6593-9428
OpenAlex ID:
A5020266258
Blockchain Enabled Online-Voting System
2020
·
Akhil Shah
, Nishita Sodhia
, et al.
·
ITM Web of Conferences
·
35
PDF
Factors influencing recruitment and retention of participants in clinical studies conducted at a tertiary referral center: A five-year audit
2020
·
Debdipta Bose
, Shruti Saha
, et al.
·
Perspectives in Clinical Research
·
17
Evaluation of genetic polymorphism of CYP3A5 in normal healthy participants from western India - A cross-sectional study
2022
·
UrmilaMukund Thatte
, MiteshkumarRajaram Maurya
, et al.
·
Indian Journal of Pharmacology
·
15
PDF
Fixed dose combination of dapagliflozin, glimepiride and extended‐release metformin tablets in patients with type 2 diabetes poorly controlled by metformin and glimepiride: A phase III , open label, randomized clinical study in India
2025
·
Rakesh Sahay
, Dinesh Gangwani
, et al.
·
Diabetes Obesity and Metabolism
·
9
PDF
An analysis of invitations for article submission received via emails
2021
·
Sandeep B Bavdekar
, Shruti Saha
, et al.
·
Indian Journal of Medical Ethics
·
7
PDF
An audit of US FDA warning letters issued to sponsors, institutional review boards and investigators over a six-year period
2021
·
Unnati Saxena
, Debdipta Bose
, et al.
·
Indian Journal of Medical Ethics
·
3
PDF
Sitagliptin, Metformin and Glimepiride Fixed‐Dose Combination Compared to Co‐Administration of Metformin and High‐Dose Glimepiride in Indian Patients With Type 2 Diabetes: A Randomised, Double‐Blind, Double‐Dummy, Phase 3 Clinical Study
2026
·
Rakesh Sahay
, Ambanna Gowda
, et al.
·
Diabetes Obesity and Metabolism
·
2
A phase III randomized, open-label, non-inferiority clinical trial comparing liquid and lyophilized formulations of oral live attenuated human rotavirus vaccine (HRV) in Indian infants
2021
·
Catherine Cohet
, Brigitte Cheuvart
, et al.
·
Human Vaccines & Immunotherapeutics
·
2
1150: Fexuprazan, a Novel Potassium-competitive Acid Blocker Vs. Esomeprazole in Indian Patients With Erosive Esophagitis: a Phase 3, Multicentre, Randomized, Active-controlled Study
2025
·
Shravan Kumar
, Santosh Hajare
, et al.
·
Gastroenterology
·
1
Clinical outcomes with a fixed-dose combination of oral montelukast and acebrophylline in bronchial asthma: a prospective, single-arm clinical study
2026
·
Rakhi Ludam
, Mayank Agrawal
, et al.
·
Journal of Asthma
PDF
Clinical outcomes with a fixed-dose combination of oral Montelukast and Acebrophylline in bronchial asthma: a prospective, single-arm clinical study
2026
·
Rakhi Ludam
, Mayank Agrawal
, et al.
·
Figshare
Efficacy and Safety of Elagolix Versus Dienogest for Treatment of Moderate‐to‐Severe Endometriosis Pain: A Phase III , Multicentric, Double‐Blind, Active‐Controlled, Non‐Inferiority Study
2026
·
Sneha Bhoir
, Jaldhara Patel
, et al.
·
BJOG An International Journal of Obstetrics & Gynaecology
Author response for "Sitagliptin, metformin, and glimepiride fixed dose combination compared to co-administration of metformin and high-dose glimepiride in Indian patients with type 2 diabetes: A randomised, double-blind, double-dummy, phase 3 clinical study"
2026
·
Rakesh Sahay
, Ambanna Gowda
, et al.
·
Publons reviews and discussion
Efficacy and safety of etifoxine versus alprazolam in generalized anxiety disorders with somatic symptoms: A randomized, double-blind, comparative study
2026
·
Kalmegh Prabhakar
, Gopalakrishnan Ganesan
, et al.
·
Journal of Anxiety Disorders
Author response for "Fixed dose combination of dapagliflozin, glimepiride and extended‐release metformin tablets in patients with type 2 diabetes poorly controlled by metformin and glimepiride: A phase III , open label, randomized clinical study in India"
2025
·
Rakesh Sahay
, Dinesh Gangwani
, et al.
·
Publons reviews and discussion
Author response for "Fixed dose combination of dapagliflozin, glimepiride and extended‐release metformin tablets in patients with type 2 diabetes poorly controlled by metformin and glimepiride: A phase III , open label, randomized clinical study in India"
2024
·
Rakesh Sahay
, Dinesh Gangwani
, et al.
·
Publons reviews and discussion
Research, residents, and registrars – getting it right
2022
·
Shruti Saha
, Nithya Jaideep Gogtay
·
Perspectives in Clinical Research
Show more works
View as search
Works count:
17
Citation count:
91
H-index:
5
I10-index:
3
Year
Topic
Type